Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS.
REPORT DATE
PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBERUniversity of Southern California Los Angeles, California 90089-9235
SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR'S ACRONYM(S)
U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012
SPONSOR/MONITOR'S REPORT NUMBER(S)
DISTRIBUTION / AVAILABILITY STATEMENTApproved for Public Release; Distribution Unlimited
SUPPLEMENTARY NOTES
ABSTRACTThe focus of this proposal was to discover susceptibility loci for overall and estrogen-receptor (ER) negative breast cancer that are particularly important for women of African ancestry. Over the past four years, we conducted the first genome-wide association study (GWAS) of breast cancer in African American women. For this effort, we were successful in establishing a consortium of breast cancer case-control studies with DNA available for genomic analysis. The GWAS, and subsequent replication genotyping of strong signals from stage 1, did not reveal any novel locus for overall breast cancer in this population. However, working with ongoing GWAS of ER-negative disease in European ancestry populations, we revealed two novel risk loci for ER-negative disease that are particularly important for women of African ancestry. We estimate that one of these loci may explain 20% of the greater risk of ER-negative disease subtypes, including triple negative disease, in women of African ancestry compared to women of other ancestries. The GWAS data have also been utilized to fine-map the more than 70 known breast cancer risk loci which has revealed generalizability of the known risk variants found in European and information that we believe will inform risk stratification in this population.
SUBJECT TERMSBreast Cancer, Genome-wide Association Study, African Americans References……………………………………………………………………………. 14 Appendices…………………………………………………………………………… 16-78
IntroductionGenome-wide association studies (GWAS) of breast cancer have been completed among populations of European ancestry, and several regions have been identified that appear to contribut...